TVM Life Science Management GmbH | WebDisclosure

Switch to English

8296	Sociétés
114902	Mots-clés
55328	Articles
62458	Communiqués

Accueil
Sociétés
TVM Life Science Management GmbH

BRÈVE

publiée le 13/03/2024 à 15:05, il y a 8 mois 7 jours

TVM Capital Life Science rejoint le sommet des technologies médicales émergentes de LSI USA '24

Stratégie D'investissement Innovation En Matière De Soins De Santé Sommet Des Technologies Médicales TVM Capital Sciences De La Vie Tendances Émergentes
COMMUNIQUÉ DE PRESSE

publié le 13/03/2024 à 15:00, il y a 8 mois 7 jours

TVM CAPITAL LIFE SCIENCE TO PARTICIPATE IN LSI USA ’24 EMERGING MEDTECH SUMMIT 2024
TVM Capital Life Science to participate in LSI USA '24 Emerging Medtech Summit 2024, showcasing industry trends & partnerships. Dr. Luc Marengère & Dr. Sascha Berger to speak on medtech innovation & AI adoption

AI Adoption TVM Capital Life Science LSI USA '24 Emerging Medtech Summit Medical Technologies
COMMUNIQUÉ DE PRESSE

publié le 06/02/2024 à 10:10, il y a 9 mois 15 jours

TVM CAPITAL LIFE SCIENCE CO-LEADS $16 MILLION SERIES A FINANCING ROUND FOR VEKTOR MEDICAL TO REVOLUTIONIZE ARRHYTHMIA CARE
TVM CAPITAL LIFE SCIENCE CO-LEADS $16 MILLION SERIES A FINANCING ROUND FOR VEKTOR MEDICAL TO REVOLUTIONIZE ARRHYTHMIA CARE. TVM Capital Life Science announces a $16 million Series A financing for Vektor Medical, a pioneer in non-invasive, AI-based arrhythmia analysis technology

Series A Financing TVM Capital Life Science Vektor Medical Arrhythmia Care AI-based Analysis
COMMUNIQUÉ DE PRESSE

publié le 31/01/2024 à 10:00, il y a 9 mois 21 jours

TVM CAPITAL LIFE SCIENCE ANNOUNCES €8 MILLION INVESTMENT IN MYO TO REVOLUTIONIZE ELDERLY CARE VIA INNOVATIVE, EASY-TO-USE APP
TVM Capital Life Science invests €8 million in Myosotis GmbH to revolutionize elderly care with innovative app, strengthening healthcare communication and administrative processes in care homes

Investment TVM Capital Life Science Myosotis GmbH Innovative App Elderly Care
COMMUNIQUÉ DE PRESSE

publié le 20/07/2023 à 14:00, il y a 1 année 4 mois

Tillotts Pharma and TVM Capital Life Science Announce Formation of Mage Biologics to Develop Innovative Oral Antibody Therapy for Ulcerative Colitis
COMMUNIQUÉ DE PRESSE

publié le 17/03/2023 à 14:00, il y a 1 année 8 mois

TVM Capital Life Science to participate in LSI USA ’23 Emerging Medtech Summit 2023
COMMUNIQUÉ DE PRESSE

publié le 23/02/2023 à 14:00, il y a 1 année 8 mois

TVM Capital Life Science Announces Promotions to Recognize Significant Contributions of Up-and-Coming Leaders
COMMUNIQUÉ DE PRESSE

publié le 08/02/2023 à 14:00, il y a 1 année 9 mois

TVM Capital Life Science Announces Creation of LAmAb Biologics to Develop Innovative Preventative Therapy for Allergy Patients
COMMUNIQUÉ DE PRESSE

publié le 01/02/2023 à 14:00, il y a 1 année 9 mois

TVM Capital Life Science announces up to USD 24 million investment in oncology company, Recurv Pharma, Inc.

Les Echos

Publié le 21/11/2024 à 06:58, il y a 6 heures 30 minutes

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Publié le 21/11/2024 à 06:58, il y a 6 heures 30 minutes

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Publié le 21/11/2024 à 06:58, il y a 6 heures 30 minutes

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Publié le 20/11/2024 à 20:07, il y a 17 heures 21 minutes

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Publié le 20/11/2024 à 19:20, il y a 18 heures 8 minutes

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

Voir tout LES ECHOS COMFI WIRE

Accesswire

Publié le 21/11/2024 à 13:00, il y a 28 minutes

Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Publié le 21/11/2024 à 13:00, il y a 28 minutes

Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Publié le 21/11/2024 à 13:00, il y a 28 minutes

Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Publié le 21/11/2024 à 13:00, il y a 28 minutes

Nextech3D.ai Spin-Out Rebrands as FOTOgpt.ai to Usher in a New Era of AI-Powered Photography
Publié le 21/11/2024 à 13:00, il y a 28 minutes

Clean Air Metals Announces Positive Results from Innovative Seismic Survey at the Escape Deposit Down-Plunge Extension

Voir tout ACCESSWIRE

EQS Group

Publié le 21/11/2024 à 13:15, il y a 13 minutes

NOTICE OF ANNUAL GENERAL MEETING
Publié le 21/11/2024 à 12:35, il y a 53 minutes

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Publié le 21/11/2024 à 12:15, il y a 1 heure 13 minutes

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Publié le 21/11/2024 à 12:06, il y a 1 heure 22 minutes

IVU AG publishes Quarterly Report Q3-2024
Publié le 21/11/2024 à 12:00, il y a 1 heure 28 minutes

Holding(s) in Company